Table 4: Univariate analyses of melatonin association with IL-33 .

Variables	Coefficient	Std. Err	t	P value	95% CI
Sex (Female)	25.75	98.91	0.29	0.70	-167.62, 225.12
Age	7.80	4.23	1.85	0.06	-0.59, 16.24
BMI	2.05	1.32	1.55	0.12	-0.58,4.70
Total cholesterol (mg/dL)	0.44	1.00	0.42	0.70	-1.60, 2.42
LDL (mg/dL)	-0.07	1.60	-0.05	0.90	-3.27, 3.12
HDL (mg/dL)	-4.80	5.90	-0.80	0.42	-16.72, 7.11
Triglyceride (mg/dL)	0.86	0.60	1.50	0.13	-0.27, 2.02
AST (U/L)	2.42	1.15	2.11	0.03	0.14, 4.70
ALT (U/L)	2.90	1.53	1.90	0.04	-0.10,6.00
ALP (U/L)	1.52	0.80	1.97	0.05	-0.02, 3.05
FBS	2.36	1.60	1.50	0.14	-0.83, 5.56
Stages of fibrosis
Mild to moderate	295.55	111.23	2.60	0.001	74.70,516.42
Severe	277.70	112.50	2.50	0.01	54.39,501.00
Stages of steatosis
Mild to moderate	30.38	134.68	0.23	0.822	-237.03, 297.79
Severe	185.72	110.99	1.67	0.098	-34.66, 406.09
Melatonin	0.42	0.90	4.75	< 0.001	0.25, 0.60

BMI: body mass index; AST: Aspartate transaminase; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; FBS: Fasting blood sugar